Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem

Rothman Institute Orthopaedics

Status: Unknown

Conditions: Total Hip Arthroplasty

Treatments: Procedure: Total Hip Arthoplasty

Study type: Interventional

Funder types: Other

Identifiers

NCT01614028

JP2012-01

Details and patient eligibility

About

This study aims to investigate short-term outcomes following the use of two femoral stems used during Total Hip arthoplasty: the Fitmore Femoral stem and the M/L Taper Femoral stem.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient signed an IRB, study specific informed patient consent.
• Patient is a male or non-pregnant female age 18 years or older at the time of study device implantation.
• Patient has primary diagnosis of non-inflammatory degenerative joint disease.
• Patient is a candidate for primary cementless total hip replacement.
• Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion criteria

• Patient has a Body Mass Index (BMI) > 40 Kg/m2.
• Patient has an active or suspected infection at the time of device implantation.
• Patient is immunologically suppressed.
• Patient requires revision surgery of a previously implanted total hip replacement.
• Patient has a known sensitivity to device materials.

Trial design

0 participants in 2 patient groups

Total Hip Arthroplasty using Fitmore femoral stem

Active Comparator group

Treatment:

Procedure: Total Hip Arthoplasty

Total Hip Arthroplasty using M/L Taper Femoral stem

Active Comparator group

Treatment:

Procedure: Total Hip Arthoplasty